Medindia LOGIN REGISTER
Medindia

USFDA Gives the Nod to Lupin to Market Its Suprax Capsules

by Savitha C Muppala on Jul 6 2012 4:43 PM

 USFDA Gives the Nod to Lupin to Market Its Suprax Capsules
Drug maker Lupin announced that it has received the new drug application (NDA) approval from the US health regulator to market its Suprax capsules in the strength of 400 mg in America.
Lupin Group President & ED Nilesh Gupta said: "The new dosage form will add to our growing Suprax franchise and gives healthcare providers and patients a new formulation to treat the indicated infections".



Source-Medindia


Advertisement